ACHN Financial Facts
Interest expense: -27KTotal operating expenses: 21.55M
See Full Income Statement
Accumulated other comprehensive income: 310K
Total current assets: 411.84M
See Full Balance Sheet
Achillion Pharmaceuticals, Inc. (ACHN) Earnings
|
Expand Research on ACHN
Next EPS Date | N/A | EPS Growth Rate | N/A |
---|---|---|---|
Average EPS % Beat Rate | -1.6% | Revenue Growth Rate | N/A |
Average % Move 1-Wk after EPS | +6.1% | Normal Earnings Time | Before Open |
Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
---|---|---|---|---|---|---|---|---|---|---|---|
3/7/19 | Q418 | -$0.12 | N/A | N/A | $12.2M | $15.4M | N/A | Details | |||
5/2/18 | Q118 | -$0.15 | -$0.14 | -$0.01 | N/A | N/A | = | Details | |||
2/22/18 | Q417 | -$0.17 | -$0.16 | -$0.01 | N/A | N/A | = | Details | |||
8/8/17 | Q217 | -$0.16 | -$0.16 | $0.00 | N/A | N/A | = | Details | |||
11/3/16 | Q316 | -$0.15 | N/A | N/A | N/A | N/A | N/A | Details | |||
5/3/16 | Q116 | -$0.13 | -$0.14 | +$0.01 | N/A | N/A | N/A | Details | |||
8/10/15 | Q215 | -$0.25 | -$0.18 | -$0.07 | N/A | N/A | N/A | Details | |||
5/7/15 | Q115 | -$0.17 | -$0.22 | +$0.05 | N/A | N/A | N/A | Details |